Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Lidocaine Transdermal Patch Market Is Expected to Grow At A CAGR of 3.2% from 2020 to 2027

Lidocaine is categorized as a local anesthetic which acts by blocking the voltage-gated sodium channel in the central nervous system. The rising prevalence of neuropathic pain and technological advancement in the transdermal drug delivery system will together drive the market growth.

Post-herpetic neuralgia is dominating the clinical application segment in the lidocaine transdermal patch market. The growing incidence of Herpes zoster viral infection due to unsafe sex practices is responsible for the disease etiology of post-herpetic neuralgia. It is also known as shingles infection, which recurs due to reactivation of the varicella-zoster viral infection. The early symptoms associate with the shingles infection is the development of cold sores in the genitalia region which is severely painful, burning sensation, and highly sensitive to touch. The joint pain will be projecting exemplary market growth on account of the growing popularity of sports and athletic activities often resulting in acute joint injuries. Additionally, increasing the geriatric population suffering from osteoporosis causing arthritis will further accentuate the market growth.

Browse the full report Lidocaine Transdermal Patch Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/lidocaine-transdermal-patch-market

Hospital pharmacy is currently ruling the distribution channel segment in the lidocaine transdermal patch market. The rising prevalence of osteoarthritis causing severe joint pains determines the market growth. Different strengths of lidocaine transdermal patch are dispensed by hospital pharmacists according to the degree of pain intensity and kind of joint pain. Retail pharmacies are garnering huge popularity as a sales channel among consumers worldwide. Flourishing generic medicines market in the developing regions further propel its market growth.

North America is currently leading the geography segment for the lidocaine transdermal patch market. The growing incidence of osteoporosis in the geriatric population causing throbbing joint pain primarily drives the market growth in the region. According to the latest information provided by the Center for Disease Control and Prevention (CDC), approximately 20.4 % population in the United States are suffering from chronic joint pain. Additionally, rising public health awareness pertaining to neuropathic pain and its treatment drives the lidocaine transdermal patch market growth in the region. Europe is placed 2nd in the regional segment due to the significant increase in the number of adults suffering from a shingles infection. As per the statistics provided by the European Commission report, the prevalence rate associated with Herpes Zoster in Europe is 2.5 per 1000 people. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period. The constant rise in the injuries associated with sports and athletic activities and flourishing over the counter analgesics market together with determining the lidocaine transdermal patch market in the region.

Pharmaceutical manufacturers actively engaged in the production of Lidocaine Transdermal Patch are Endo International, Plc., Mylan N.V., Teva Pharmaceutical Industries, Ltd., Hisamitsu Pharmaceuticals Co., Inc., Sorrento Therapeutics, Inc., Galen Limited, Seqirus Pty Ltd., ACTAVIS LABS UT INC, CERAMISPHERE and Aetna, Inc.

Key Market Movements:

  • Rising prevalence of shingles infection among the adult population worldwide
  • Significant increase in the number of musculoskeletal disorders causing throbbing joint pains will further accentuate the market growth
  • Technological advancement in the transdermal drug delivery system to provide local anesthetic effect will further propel the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Electrosurgical Cutting Forceps Market is expected to grow at a CAGR of 6.0% from 2020 to 2027

The primary purpose of electrosurgical devices is caused to prevent the bleeding by causing the coagulation of tissue at the site of surgery with the help of either Monopolar or bipolar forceps. Technological advancement in the electrochemical devices and increasing demand for minimally invasive surgical procedures drive the electrosurgical cutting forceps market growth.

In the present situation, the Monopolar forceps are dominating the types segment for the electrosurgical cutting forceps market. The major factors contributing to its market dominance are its applicability in surgical procedures requiring a high degree of tissue desiccation, vaporization and coagulation, and fulguration. Bipolar forceps have gained tremendous demand in the last decade owing to its ability to perform laparoscopic surgical procedures worldwide. Furthermore the ability to coagulate tissue in a fluid environment, and the flow of current being limited to the surgical site ultimately results in the prevention of tissue burns and damages.

Browse the full report Electrosurgical Cutting Forceps Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 report at https://www.atlanticmarketresearch.com/electrosurgical-cutting-forceps-market

Hospitals and clinics are currently representing the largest end-user market for the electrosurgical cutting forceps. Significant rise in the number of outpatient admissions to undergo the surgical procedure as the only viable treatment option for chronic diseases. Huge funding by healthcare agencies worldwide to provide technological advanced electrosurgical devices to hospitals and clinics worldwide. Ambulatory surgical centers are gaining huge traction owing to its ability to drastically reduce the healthcare cost burden of ailing patients and a significant rise in the number of inpatient population opting minimally invasive surgical procedures throughout the globe.

North America is presently spearheading the geography segment for the electrosurgical cutting forceps market. As per the research findings brought forward by the U.S. Department for Health & Human Services in 2018, approximately 129 million outpatient surgeries were performed in the United States. The chief contributing factors such as increasing demand for non-invasive surgical procedures and the presence of key players such as Aesculap, Inc., Elite Medical, CONMED Corporation, Stryker, etc. further promote a positive impetus to the electrosurgical cutting forceps market growth in the region. In Europe, the market growth is defined by the proactive role adopted by the European Medical Agency (EMA) for the early clearance of electrosurgical devices. Western Europe has been pioneering in the manufacturing of invasive and noninvasive surgical devices for centuries and is anticipated to continue the trend during the forecast period. The Asia Pacific is expected to register comfortable growth in the near future owing to the significant rise in medical tourism. The constant rise in the ambulatory surgical centers to address emergency situations in the remote areas further propels the market growth in the region.

Medical device manufacturers engaged in the production of electrosurgical devices are Aesculap, Inc., Erbe Elektromedizin GmbH, Elite Medical, Medtronic, Plc., Ethicon, Inc., Bovie Medical, CONMED Corporation, Bissinger Medizintechnik GmbH, Stryker and BOWA-electronic GmbH & Co. KG.

Market key Takeaways:

  • Significant increase in the number of surgical procedures performed as the only treatment option for chronic diseases
  • Technological advancement in the development of Monopolar and bipolar forceps minimizing tissue burns and damages
  • Increasing demand for minimally invasive surgical procedures and constant rise in the ambulatory surgical centers together drive the electrosurgical cutting forceps market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Mothballs Market is expected to grow at a CAGR of 5.4% from 2020 to 2027

Mothballs produce fumes which curb the manifestation of moths, larvae, and eggs. The synthetic mothballs produce toxic fumes as they are sublime in nature and can prove toxic on exposure to children. Naphthalene mothballs and 1,4 paradichlorobenzene have potent carcinogenic properties and hence there is been an increasing demand for nontoxic natural mothballs which is moth repellant and deodorant.

The synthetic mothballs are holding the largest market in the type segment for the mothballs market. Chemical moieties such as naphthalene and 1,4 dichlorobenzene are used in manufacturing synthetic mothballs owing to its excellent physicochemical properties such as heat resistance and sublime nature that produces toxic vapors which curbs the manifestation of moths, larvae and eggs in closet, house pantry and toilets. Natural mothballs are manufactured using chemical moieties such as cedarwood oil, camphor oil, and lavender oil, which has potent moth repellent properties and produces good fragrance in closed indoor areas.

Browse the full report Mothballs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/mothballs-market

Household demand for mothballs is on a constant rise as the heated house ventilation in cold winters promotes the manifestation of moths. The huge destruction caused to costly textiles, fabrics, cereals, and grains further fortify the household demand for mothballs. The commercial demand for mothballs is increasing due to a concomitant rise in the pest management industry. The availability of mothballs as flakes, marbles, blocks, and cases provides excellent deodorization and sanitation in huge commercial spaces and retail outlets.

North America is considered the largest market for mothballs on account of the climatic conditions which produces excellent breeding grounds for gypsy moths which causes huge destruction of wooden furniture made from hardwood and conifer. Mothballs containing pheromones are currently being used in the Eastern coast of the United States to prevent the spread of gypsy moths westwards. The presence of key players such as Enoz, Boxania, Hovex, Merck Millipore, etc. further provides a positive stimulus to the mothball market growth in the region. In Europe the heated house ventilation during the cold winters provides beneficial breeding grounds for cloth moth and pantry moth which causes destruction of costly textiles, fabrics, cereals, and grains. Chemical companies and academic research institutes are collaborating for the development of natural mothballs and pheromones to curb the manifestation of moths, larvae, and eggs in closed indoor areas in the Eastern Europe region. It is expected that the Asia Pacific will register positive market growth in the forecast period on account of unhygienic sanitary conditions in the house pantry and the emergence of local players pioneering in the production of synthetic mothballs.

Chemical companies engaged in the production of mothballs are Enoz, Boxania, Hovex, Henkel Ltd., Wego Chemical Group, Merck Millipore, Sigma Aldrich, Pan Chem Corporation, Roeper GmbH, and Hangerworld Ltd.

Market Key Takeaways:

  • Constant rise in the manifestation of clothing moth and pantry moth due to heated house ventilation in cold winters
  • Increasing demand for natural mothballs owing to its non-toxic nature and availability in attractive fragrances
  • Mothballs are being developed by addition of pheromones to trap moths in closed indoor areas

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Leuprolide Acetate Market Is Expected to Grow At A CAGR of 3.8% from 2020 to 2027

Leuprolide acetate exerts its pharmacological effect by suppressing the gonadotropin secretion of luteinizing and follicle-stimulating hormone which finally suppresses the gonadal sex steroid production. It is under clinical trial investigation for determining its therapeutic efficacy and safety in the treatment of polycystic ovary syndrome, premenstrual syndrome, functional bowel diseases, etc.

Endometriosis is dominating the clinical application segment for the leuprolide acetate market. According to the recent statistics provided by the American Cancer Society (ACS), approximately 10% of the women population worldwide are suffering from endometriosis. Shorter menstrual length, early age at menarche, and taller heights are associated with an increased risk of occurrence of endometriosis. It severely affects the social life of a woman during her reproductive age. Prostate cancer is going to highlight excellent market growth during the forecast period owing to the significant increase in geriatric men population suffering from prostate cancer worldwide. As per the latest research citings provided by the International Agency for Research on Cancer (IARC), prostate cancer accounts for almost 15% of all incident cancer cases in men population throughout the globe.

Browse the full report Leuprolide Acetate Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/leuprolide-acetate-market

Hospital pharmacy is currently representing the largest market share in the distribution channel segment for leuprolide acetate market. The drug is prescribed by oncologists for its diverse clinical application, hence accurate compounding of the medicine is mandatory to negate the occurrence of drug-related adverse events. Retail pharmacy is expected to showcase rapid market growth in the near future due to flourishing generic drugs market demand in the developing regions and its ability to provide medicines to patients residing in remote locations.

North America is presently leading the geography segment for the leuprolide acetate market. The rising prevalence of endometriosis primarily drives market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), it is estimated that approximately 11% of the American women population aged 15 to 44 years old suffer from endometriosis. Furthermore, the domicile of major players such as Abbvie, Inc., Sandoz, Inc., Tolmar Pharmaceuticals, etc., further drive the market growth in the region. Europe is placed 2nd in the regional segment for the leuprolide acetate market. The existence of developed healthcare infrastructure and affordable reimbursement scenario for leuprolide acetate drug formulation determine the market growth. The Asia Pacific is anticipated to be the fastest-growing regional segment for the leuprolide acetate market. Growing incidence of central precocious puberty and developing healthcare infrastructure together accentuate the market growth.

Pharmaceutical manufacturers actively engaged in the production of Leuprolide Acetate are Abbvie, Inc., Sandoz, Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Inc., Sun Pharmaceutical Industries Ltd., Sanofi Aventis, Tolmar Pharmaceuticals, MundiPharma, Cipla Limited, and Bayer Pharmaceuticals Corporation.

Key Market Movements:

  • Rising prevalence of endometriosis in women and prostate cancer in men population worldwide
  • Researchers diligently working to develop leuprolide acetate drug formulation for the treatment of central precocious puberty among children throughout the globe
  • Affordable reimbursement scenario for leuprolide drug formulation will further propel the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Wound Closure Strips Market Is Expected To Grow At A CAGR Of 7.3% From 2019 To 2027

World Health Organization (WHO), has recommended physicians to cover acute and chronic wounds as open tissue injuries are susceptible to bacterial injuries. Looming threat of surgical site infection and superbug infection in hospitals increase the demand for wound closure strips throughout the globe. Zipline wound closure strips and micro anchors wound closure strips are gaining prominence among surgeons worldwide. Strategic collaboration between pharmaceutical companies to increase their product portfolio for wound closure devices. The major hurdle faced by this market is by the stiff competition imposed by the demand for surgical staples and sutures for acute and chronic wounds.

Elastic wound closure strips are spearheading the types segment. The chief factors responsible for its market growth are its flexibility to stretch according to different body movement without compromising on the comfort level. It is the most ideal wound closure strip for contoured body surface which is susceptible to swelling and edema. The reinforced wound closure strips find a huge application for covering wounds obtained due to deep lacerations and surgical incisions.

Browse the full report Wound Closure Strips Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/wound-closure-strips-market

Hospitals & clinics are holding the largest market share for the end-user segment in the wound closure strips market. Significant rise in the number of surgeries performed and constant rise in the inpatient admission to a medical emergency and surgery centers due to fatal accidents drive the market growth for the hospital & clinics. Household demand for wound closure strips are gaining tremendous traction on account of the injuries caused due to laceration and cuts obtained while performing daily household chores. The ease and convenience in the application of wound closure strips further bolster its demand for the protection of wounds associated with household injuries.

North America held the largest market in 2018, in the geography segment for the wound closure strips market. The major contributing factors pertaining to its market growth are a significant rise in the number of surgeries performed and the looming threat associated with surgical site infection. The market growth of Europe is dependent on parameters such as the presence of key players such as 3M Company, Cardinal Health, Inc., Smith & Nephew, Plc. etc. The proactive role adopted by the European Medical Agency (EMA) for the early clearance of wound closure devices further accentuates the market growth in the European Union region. Asia Pacific will be showcasing affirmative growth during the forecast period owing to the significant rise in fatal accidents associated with road and highway vehicle collision and occupational hazards.

Pharmaceutical companies engaged in the manufacturing of wound closure strips are Cardinal Health, Inc., DeRoyal Industries, Inc., DermaRite Industries, LLC., Dynarex Corporation, 3M Company, Hill-Rom Holdings, Inc., Medline Industries, Inc., McKesson Corporation, Integra LifeSciences Holdings Corporation, and Smith & Nephew, Plc.

Market Key Takeaways:

  • Significant rise in the number of surgical procedures performed and surgical site infection worldwide
  • Strategic collaboration between pharmaceutical companies to increase their product portfolio pertaining to wound closure devices
  • Rising prevalence of fatal accidents related to roadside vehicle collision and occupational hazards

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Disposable Infusion Sets Market Is Expected to Grow At A CAGR of 4.7% from 2020 to 2027

The disposable infusion set is used in combination with either a needle or catheter administering the drug via the intravenous route. A significant increase in rehabilitation centers and home care settings for the treatment of geriatric and pediatric patients suffering from chronic diseases will increase the demand for disposable infusion sets during the forecast period.

Polyvinyl chloride (PVC), is representing the largest market share in the material segment for disposable infusion sets market. The positive attributes related to PVC which makes it the raw material of first preference among polymers for the production of disposable infusion sets are transparency, good resistance to sterilization, ease of sealing, high tensile strength, low manufacturing cost, etc. The plasticizing capacity of polyvinyl chloride is enhanced by cross-linking the polymer with subunits of Polyethylene and DEHP, which enhances the flexibility of polyvinyl chloride. In the near future, it is assumed that polyolefin will be showcasing impressive market growth on account of enhanced biocompatibility and non-reactivity with the drug particle being delivered via the intravenous route.

Browse the full report Disposable Infusion Sets Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/disposable-infusion-sets-market

Hospitals & clinics are spearheading the end-user segment for disposable infusion sets market. As per the research citings by the World Health Organization (WHO), cancer is the second largest cause of death worldwide thereby increasing the requirement of chemotherapy in ailing patients using disposable infusion sets. Ambulatory surgical centers are expected to highlight steady market growth during the forecast period on account of the growing incidence of pandemic outbreaks of life-threatening infectious diseases requiring intravenous antibiotic administration via disposable infusion sets.

North America is currently dominating the geography segment for disposable infusion sets market. A significant increase in patients suffering from chronic diseases receiving medication via disposable infusion sets determines the market growth in the region. As per the recent information provided by the Center for Disease Control and Prevention (CDC), the healthcare burden associated with the treatment of chronic diseases in the United States is 3.5 trillion dollars each year. The supportive regulatory environment provided by the USFDA for the early CE certification of disposable infusion sets bolsters the market growth in the region. Europe is the second-largest regional segment for disposable infusion sets market. Domicile of key players such as Baxter AG, Rays S.P.A., Fresenius Kabi Ltd., Vygon SA, etc, drives the market growth in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for disposable infusion sets market. Proactive government initiatives in sponsoring government hospitals for purchase of disposable infusion sets and constant growth observed in the contract manufacturing organization engaged in the production of surgical devices in the Asia Pacific region.

Surgical device manufacturers actively engaged in the production of disposable infusion sets are LILY MEDICAL CORPORATION, Baxter AG, Fresenius Kabi Ltd., Nipro Corporation, Vygon SA, Smiths Medical, Becton Dickinson & Company, B?çakc?lar, Terumo Medical Corporation, and Rays S.P.A.

Key Market Movements:

  • Growing incidence of infectious diseases increases the demand for disposable infusion sets
  • Rising prevalence of cancer and other chronic diseases requiring intravenous drug administration via disposable infusion sets throughout the globe
  • Supportive regulatory environment for the early CE clearance and adoption of disposable infusion sets worldwide

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Audiometric Screening Equipment Market Is Expected to Grow At A CAGR of 6.6% from 2020 to 2027

According to the statistics provided by the World Health Organization (WHO), by 2050 it is estimated that 1 in 10 people will be suffering from hearing disability worldwide. Technological advancement in the audiometric screening equipment will drive the market growth in the near future.

Conductive hearing loss is dominating the largest market share in the indication segment for audiometric screening equipment. It occurs when the sound is blocked either in the outer ear canal or the middle ear. The chief causative factors associated with the disease etiology are patients suffering from otosclerosis and cerumen impaction. Recurrent episodes of tinnitus and infection of Eustachian fluid infection may result in the development of conductive hearing loss. Sensorineural hearing loss will be registering rampant market growth in the indication segment for the audiometric screening equipment market. The key parameters responsible for the disease prognosis are listening to loud noise or explosion, blow to the head, aging, etc.

Browse the full report Audiometric Screening Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/audiometric-screening-equipment-market

Hospitals are currently leading the end-user segment for audiometric screening equipment market growth. Rising prevalence of otitis media infection and rising noise population causing trauma to eardrums has resulted in frequent patients visits to the hospital for initial screening and treatment for ear diseases. Specialty clinics are expected to record steady market growth during the forecast period owing to the significant increase in the congenital hearing disability in children and proactive government initiatives to establish specialty clinics to reduce the healthcare burden associated with government-sponsored hospitals.

North America is reigning the geography segment for the audiometric screening equipment market. According to the latest information provided by the American Speech-Language-Hearing Association (ASHA), the prevalence rate of hearing loss is 2 to 3 per 1000 children in the United States. Furthermore, clinical research studies have elucidated that approximately 15% of the United States population is suffering from hearing loss. Domicile of key players such as MAICO Diagnostics, Vivosonic, Inc., Natus Medical Incorporated., etc. further propels the market growth in the region. Europe is considered as the second-largest regional segment owing to the rising prevalence of presbycusis. As per the latest research citings presented by the World Health Organization approximately 33% of the geriatric population above 65 years of age suffer from some hearing defect in the Asia Pacific region. A significant increase in the otitis media infection eventually causing injury to the eardrums will further accentuate the market growth in the region.

Medical device manufacturers actively engaged in the production of audiometric screening equipment are MAICO Diagnostics, OTODYNAMICS LTD., Intelligent Hearing Systems, Natus Medical Incorporated, Vivosonic, Inc., INVENTIS SRL., AUDITDATA A/S, Benson Medical Instruments Co., 3M Company and Demant A/S.

Key Market Movements:

  • Rising prevalence of otosclerosis and presbycusis in the adult population worldwide
  • Growing incidence of congenital hearing defects in children throughout the globe
  • Proactive initiatives adopted by government healthcare agencies to invest huge funds in procuring audiometric screening equipment to diagnose and treat ear defects

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Pretreatment Coatings Market is expected to grow at a CAGR of 5.4% from 2020 to 2027

Effective pretreatment partly depends on the good chemical formulation and robust system which controls temperature, duration, and flow of the pretreatment coatings process. It is rendered as a sustainable method to achieve corrosion resistance and improve paint adhesion on metal surfaces.

Phosphates are representing the largest market share in the types segment for the pretreatment coatings market. They are the most preferred coating used as a pretreatment on zinc, iron, steel and its alloys. The ergonomic features pertaining to phosphates are corrosion resistance and increase the paint adhesion on the pretreated metal surface. Chromate conversion coatings are widely used on aluminum and its alloys to resist corrosion without losing the electrical conductivity of the metal surface. Stringent regulatory norms sanctioned by EPA, REACH, etc. has put its end-use application under scrutiny due to its environmental hazardous properties. Chromate free coating will be the fastest-growing segment on account of its immense popularity in the aerospace and military vehicles as a pretreatment coating.

Browse the full report Pretreatment Coatings Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/pretreatment-coatings-market

Automotive is currently leading the end-user segment for the pretreatment coatings market. The major parameter responsible for its superior market growth is the capability of pretreatment coating to reduce maintenance cost, resistance to corrosion, and increase shelf life of the automobiles. Building and construction are highlighting sturdy market growth owing to the rise in per capita income and increasing urbanization in the developing regions such as Asia Pacific and Middle East & Africa. The aerospace segment is estimated to record rapid market growth in the near future on account of the rising demand for air travel in comparison to other modes of commutation in the developed regions.

Asia Pacific is dominating the geography segment for the pretreatment coatings market. The major attributes responsible for its market dominance is the significant increase in the demand for automobiles in China, Japan, India, South East Asia, etc. Furthermore, the rise in per capita income has resulted in promising growth in the building & construction segment. Europe stands 2nd in the regional segment for the pretreatment coatings market. Increasing demand for air travel and constantly growing aerospace sector drives the pretreatment coatings market growth in the region. North America offers promising growth for pretreatment coatings on account of the burgeoning demand for household and electrical appliances and the flourishing automobile industry. Middle East & Africa is anticipated to be the fastest-growing regional segment during the forecast period. Wealth diversifying strategies adopted by oil-producing nations to expand the building & construction segment in the region bolsters market growth.

Chemical and paint manufacture actively engaged in providing pretreatment coatings are Chemetall GmbH (BASF), AkzoNobel N.V., Abrasives Inc., PPG Industries, Inc., Nippon Paints Holding Co., Ltd., Axalta Coating Systems, Vanchem Performance Chemicals., Henkel AG & Co. KGaA., Arrow Cryogenics, Inc., and Barton International, Inc.

Market Key Takeaways:

  • A rise in per capita income has provided a positive impetus to the building & construction market growth
  • Significant increase in air travel as compared to other modes of commutation drives the pretreatment coatings market
  • Progressive research and development to manufacturing chromate-free protective coatings to maintain environmental safety norms

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Neurotrophic Keratitis Market is anticipated to expand at a CAGR of 5.1% from 2019 to 2027

The major symptoms associated with neurotrophic keratitis are red & dry eyes, blurred vision, pain, and discomfort in the eye. Approval of promising drugs such as Oxervate and TB4 is going to completely revolutionize the treatment regimen for neurotrophic keratitis during the forecast period.

National Organization for Rare Disease has designated neurotrophic keratitis is a rare disease highlighting a prevalence rate of 5 per 10,000 people. The major causative agent is the herpes zoster virus and herpes simplex virus. The clinical manifestation of the disease is the progressive damage of nerve innervations of the trigeminal nucleus present in the corneal region of the eye. It results in obliteration of the healing process of the corneal surface. Ophthalmologists across the globe are adopting a treatment regimen on the basis of the different stages of the disease. Preservative-free artificial tears are dominating the medication segment owing to its capability to provide lubrication and moisture, it initiates lacrimation to ensure eye hygiene. Regenerative human nerve growth factors will be influencing the market during the forecast period owing to its effective therapeutic index against neurotrophic keratitis infection. The surgical intervention segment is further classified as tarsorrhaphy and amniotic membrane transplantation, they are proven beneficial during the 3rd stage of the infection for the treatment of corneal ulcer.

Browse the full report Neurotrophic Keratitis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/neurotrophic-keratitis-market

North America is presently is spearheading the geography segment in the neurotrophic keratitis market. According to the vital statistics provided by the National Institute of Health (NIH) research for ophthalmology disorders, the prevalence rate of the population undergoing surgical intervention for neurotrophic keratitis is 1.5 per 10,000 population. Furthermore, herpes zoster has been identified as the major causative agent to initiate the prognosis of neurotrophic keratitis in the North American region. Chief contributing factors such as high incidence rate and affordable reimbursement scenario accentuates the growth of neurotrophic keratitis in the region. Europe is the 2nd largest regional market for neurotrophic keratitis treatment owing to proactive role adopted by European Medical Agency (EMA) to expedite the drug development protocols pertaining to neurotrophic keratitis Effective research partnership between biopharmaceutical companies and academic research institutes specializing in eye care further support the market growth in Europe region. The Asia Pacific is showcasing promising growth in the near future on account of the rising prevalence of neurotrophic keratitis in the elderly population and developing healthcare infrastructure relevant to ophthalmology research and care centers.

Biopharmaceutical companies pioneering in the treatment of neurotrophic keratitis are Allergan, Plc., Dompe farmaceutici S.p.A., Abbott Laboratories, Inc., CooperVision, Neuroptika, Bausch & Lomb Incorporated, ReGenTree, LLC., Bayer AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Novartis AG.

Market Key Takeaways:

  • The exponential rise in the incidence rate of neurotrophic keratitis throughout the globe
  • Affordable reimbursement scenario for the medications employed in the treatment for 1st and 2nd stage neurotrophic keratitis
  • USFDA has awarded priority review designation to facilitate the market growth of Oxervate in developed regions such as as Europe and North America

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Gait Rehabilitation System Market Is Expected to Grow At A CAGR of 8.2% from 2020 to 2027

According to the latest research citings provided by the world health organization (WHO), the prevalence rate of stroke in the Caucasian population is 500–600 per 100,000 people worldwide. A multidisciplinary approach is being utilized by physiotherapists in understanding the entire aspects of the physical and psychological requirements of ambulation in daily life multitasking.

Gait trainer walkers are reigning the product type segment for the gait rehabilitation system market. The gait trainer walker can be custom made according to the age and ambulatory functions of the concerned individual. Research studies have reported the benefits associated with gait trainers such as its ability to stimulated spatial awareness and neural function related to ambulatory functions of the limbs. Furthermore, it is very beneficial in enhancing cardiopulmonary strengthening and conditioning in patients suffering from a stroke. Robot-assisted gait rehabilitation is expected to register impressive market growth in the near future on account of its ability to develop robotic walking simulation which is based on the principle of programmable footplates which encourages arbitrary walking situations and foot trajectories. The pelvic assist manipulator is a very helpful system that is critical in evaluating the pelvic movement and trajectory via the mechanical action of the pelvis and its effect on the lower limbs. Manufacturers are developing robots which stimulate different neural circuits by performing several rhythmic and discrete movement of the limbs.

Browse the full report gait rehabilitation system market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/gait-rehabilitation-system-market

Hospitals & clinics are leaders in the end-user segment for the gait rehabilitation system market. A constant rise in fatal accidents and occupational hazards severely affecting the limbs primarily drives the hospitals and clinic’s market growth. Rehabilitation centers are gaining tremendous importance is the last 2 decades owing to its ability to serve patients suffering from Parkinsonism, muscular dystrophy, etc.

North America is presently dominating the geography segment for the gait rehabilitation system market. Rising prevalence of spinal injuries causing gait disabilities primarily drives the market growth in the region. As per the latest research citings presented by the Center for Disease Control and Prevention (CDC), approximately 17,730 new cases of spinal cord injuries causing paralysis are reported each year in the United States. Domicile of key players such as Otto Bock, Inc., Ekso Bionics Holdings, Inc., Cyberdyne, Inc., etc. will further propel the market growth in the region. Europe is placed 2nd in the regional segment owing to the rising prevalence of cerebral palsy in children determines the market growth in the region. The Asia Pacific is anticipated to register the fastest market growth during the forecast period chiefly due to the rising prevalence of osteoporosis in the geriatric population thereby drastically affecting their ambulatory functions.

Medical device manufacturers actively engaged in the production of gait rehabilitation systems are Otto Bock, Inc., Ekso Bionics Holdings, Inc., Rex Bionics, Ltd., ReWalk Robotics, Inc., medica Medizintechnik GmbH., Kinova, Inc., Cyberdyne, Inc., Hocoma, AG (DIH International Limited), Bionik Laboratories Corporation and AlterG, Inc.

Key Market Movements:

  • Rising prevalence of neurological and spinal disorders causing gait disabilities worldwide
  • Technological advancement in the robot rehabilitation systems further accentuate the market growth
  • Supportive regulatory environment provided by the global regulatory bodies for the early adoption of gait rehabilitation systems

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Corticosteroid Nasal Sprays Market Is Expected To Grow At A CAGR Of 4.5% From 2020 To 2027

The latest information provided by the American Academy of Allergy Asthma and Immunology (AAAAI), it is estimated that 10-30 percent of the global population is suffering from allergic rhinitis. Rising prevalence of chronic rhinosinusitis and seasonal flu together will drive the corticosteroid nasal sprays market. The major hurdle faced by this market is the intense competition imposed by the antihistaminic nasal sprays for providing symptomatic relief of the upper respiratory tract infections.

Budesonide is presently spearheading the drug class segment for corticosteroid nasal sprays market. It is used as first-line therapy for attenuating the inflammation associated with seasonal allergic rhinitis and is crucial in providing symptomatic relief such as itching sneezing and runny nose. Fluticasone is will showcase magnificent market growth in the near future owing to its therapeutic efficacy in the treatment of nasal polyps and significantly reduces the inflammation associated with chronic rhinosinusitis. Triamcinolone is frequently prescribed by pediatricians for treating seasonal flu and allergic rhinitis in children’s belonging to the age group of 2 to 5 years owing to its therapeutic efficacy and safety.

Browse the full report Corticosteroid Nasal Sprays Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/corticosteroid-nasal-sprays-market

Hospital pharmacy is leading the distribution channel segment for corticosteroid nasal sprays market. The chief contributing factor catering to its positive market growth is a significant increase in the number of patients visiting hospital pharmacies with a prescription for the treatment of seasonal allergic rhinitis. The retail pharmacy has gained tremendous traction in the last decade on account of the availability of corticosteroid nasal sprays as the over the counter products.

North America is dominating the geography segment for corticosteroid nasal sprays market. According to the latest research citings brought forward by the National Ambulatory Medical Care Survey (NAMCS), approximately 35 million United States citizens are reported to be suffering from rhinosinusitis per year. Additionally, the favorable reimbursement scenario for the use of prescribed corticosteroid nasal sprays further propels its market growth in the region. Europe is at the 2nd place on account of the rising prevalence of allergic rhinitis across all age groups in the region. As per the statistics provided by the European Academy of Allergy and Clinical Immunology approximately 100 million Europeans suffer from allergic rhinitis infection. Asia Pacific is keen to register magnificent market growth in the near future on account of the tropical weather of SE Asian countries that is suitable for the disease progression of seasonal flu infection. The existence of a developed generic market accentuates the corticosteroid nasal sprays market in the Asia Pacific.

Pharmaceutical companies engaged in the production of corticosteroid nasal sprays are AstraZeneca AB, Chattem, Inc., GlaxoSmithkline, Plc., OptiNose US, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Sandoz, Inc., Perrigo Company, Plc., and Pfizer, Inc.

Market Key Takeaways:

  • Rising prevalence of allergic rhinitis and chronic rhinosinusitis throughout the globe
  • Affordable reimbursement scenario for the corticosteroid nasal sprays prescribed for treating seasonal and allergic reactions of the upper respiratory tracts
  • Presence of generic market in developing countries and availability as over the country products in developed countries together drive corticosteroid nasal sprays market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market

COVID-19 Impact on Global Biochemical Diagnostic Reagent Market Insights, Forecast to 2026

In this report, the COVID-19 Impact on Global Biochemical Diagnostic Reagent market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2019 and 2026. COVID-19 Impact on Global Biochemical Diagnostic Reagent market has been broken down by major regions, with complete market estimates on the basis of products/applications on a regional basis.

Browse full research report at https://www.crystalmarketreport.com/covid-19-impact-on-global-biochemical-diagnostic-reagent-market-insights-forecast-to-2026

Crystal Market Reports

Biochemical reagents are mainly used for instrumentation, such as manual, semi-automatic and general automatic biochemical analyzers.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biochemical Diagnostic Reagent market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Biochemical Diagnostic Reagent industry.

Based on our recent survey, we have several different scenarios about the Biochemical Diagnostic Reagent YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biochemical Diagnostic Reagent will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biochemical Diagnostic Reagent market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biochemical Diagnostic Reagent market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Biochemical Diagnostic Reagent market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Production and Pricing Analyses

Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Biochemical Diagnostic Reagent market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Biochemical Diagnostic Reagent market has been provided based on region.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Biochemical Diagnostic Reagent market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Biochemical Diagnostic Reagent market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biochemical Diagnostic Reagent market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biochemical Diagnostic Reagent market.

The following manufacturers are covered in this report:

Roche

Siemens Healthineers

Beckman Coulter

Randox

BioSino

Beijing Leadman Biochemistry

FosunPharma

Beijing Strong Biotechnologies

Dojindo Laboratories

Sysmex

KAINOS Laboratories

DAAN Gene

Biochemical Diagnostic Reagent Breakdown Data by Type

Liquid Double Reagent

Dry Powder Double Reagent

Biochemical Diagnostic Reagent Breakdown Data by Application

Hospital

Clinic

Laboratory

Browse full research report at https://www.crystalmarketreport.com/covid-19-impact-on-global-biochemical-diagnostic-reagent-market-insights-forecast-to-2026

Reasons to Buy This Research Report

About Crystal Market Reports

Crystal Market Reports is a distributor of market research spanning 160 industries. Our extensive database consists of over 400,000 quality publications sourced from 400 plus publishers, this puts our research specialists in the unique position of been able to offer truly unbiased advice on what research provides the most valuable insights.

Contact Info.:-

Address: 911 Central Avenue #268
Albany New York 12206
Email: [email protected]
Phone: 1-518-730-1569
Web: https://www.crystalmarketreport.com

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Glaucoma Drugs Market is expected to grow at a CAGR of 4.0% from 2020 to 2027

According to the latest statistics provided by the International Agency for the Prevention of Blindness (IAPB) by 2020, approximately 3.2 million people will be reported blind due to glaucoma. Researchers are working on developing novel drug development for the treatment of glaucoma.

Prostaglandins are spearheading the drug class segment for the glaucoma drug market. They are currently used as a first-line therapy due to positive patient compliance as only a single dose is required daily, it acts by relaxing muscles of the eyes interior structure in order to promote fluid drainage and reduce eye pressure. Beta-blockers are used in combination with prostaglandins for the treatment of glaucoma, it is helpful in the treatment of glaucoma by reducing the fluid production in the eye. Carbonic anhydrase inhibitors and alpha-adrenergic agonists are used in combination with other drugs that are employed when it is eminent to decrease the rate of aqueous humor production in glaucoma patients. The recent launch of novel drugs employed in glaucoma management such as Rhopressa and Vyzulta which have superior therapeutic efficacy and safety in comparison to traditional drugs will be the fastest-growing drug class.

Browse the full report Glaucoma Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/glaucoma-drugs-market

Hospital pharmacy is dominating the distribution channel segment for the glaucoma drugs market. Precise compounding of glaucoma drugs especially in combination therapy is important to prevent drug-related side effects, hospital pharmacist is vital in dispensing glaucoma drugs according to the prescription. The retail pharmacy will be the fastest-growing distribution channel segment during the forecast period on account of its ability to provide generic versions of glaucoma drugs at attractive prices.

North America is leading the geography segment for the glaucoma drugs market. A significant increase in the number of glaucoma cases primarily drives the glaucoma drug market in the region. According to the recent research findings presented by BrightFocus Foundation glaucoma is the leading cause of blindness among Hispanics and African Americans. Furthermore, the existence of well-developed healthcare infrastructure and the presence of major players such as Allergan, Plc., Alcon, Bausch & Lomb, Novartis AG, etc. buttress the market growth in the region. Europe is considered as the second-largest regional market due to the supportive regulatory environment provided by the European Medical Agency (EMA) for the sale and distribution of glaucoma drugs and affordable reimbursement scenario for glaucoma drugs in the region. Asia Pacific is set to be the fastest-growing regional market for glaucoma drugs chiefly due to the rising prevalence of glaucoma in the elderly population and the presence of flourishing generic drugs market.

Pharmaceutical companies actively engaged in the manufacturing of glaucoma drugs are Allergan, Plc, Alcon, Novartis AG., Merck KGaA, Pfizer, Inc., Aerie Pharmaceuticals, Inc., Bausch + Lomb, Inotek Pharmaceuticals, Teva Pharmaceutical Industries, Ltd., and Santen Pharmaceutical Co., Ltd.

Market Key Takeaways:

  • Significant increase in the number of people suffering from glaucoma worldwide
  • Recent launch of novel drugs for management of glaucoma such as Rhopressa and Vyzulta will further accentuate the market growth
  • Affordable reimbursement scenario for the glaucoma drugs used in the treatment propels the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Medical Mechanical Ventilators Market Is Expected to Grow At A CAGR of 3.2% from 2020 to 2027

The present scenario of COVID-19 infection which severely damages the respiratory system of the infected person has led to the tremendous demand for mechanical ventilators throughout the globe. Increasing consumption of tobacco at an early age, rising air pollution, and a significant increase in surgical procedures for the treatment of chronic diseases together consolidate the medical mechanical ventilators market growth.

Intensive care are representing the largest market share in the product segment for the mechanical ventilators market. A significant rise in pandemic RNA viral diseases causing damage to the respiratory functions of ailing patients increases the demand for intensive care mechanical ventilators. Increasing growth observes in specialty clinics will further fortify market growth. Neonatal mechanical ventilators will record marvelous market growth during the forecast period on account of the rising prevalence of Down syndrome and spina bifida in the neonates worldwide.

Hospitals & clinics are currently dominating the end-user segment for the medical mechanical ventilators market. Rising prevalence of chronic bronchitis due to the constant rise in smoking and air pollution primarily drives the market growth. A significant increase in the neonates born with congenital deficiency and preterm births will further bolster the market growth. Ambulatory surgical centers are expected to showcase impressive market growth in the near future primarily due to its ability to reach the site of accidents and immediately provide medical aid to victims to maintain their homeostasis.

Browse the full report Medical Mechanical Ventilators Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/medical-mechanical-ventilators-market

North America is presently leading the geography segment for the medical mechanical ventilators market. The rising prevalence of cystic fibrosis in an aging population with chronic smoking history primarily drives the market growth in the region. According to the latest research citings presented by the American Lung Association (ALA), the chronic obstructive pulmonary disease is the 4th largest cause of death in the United States. Domicile of major players such as GE Healthcare, Koninklijke Philips N.V., Smiths Medical, etc. will further bolster the market growth in the region. Europe is the second-largest regional segment on account of the early CE certification provided by the European Medical Agency (EMA), for its high rate of adoption and installation in the government-sponsored hospitals. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period on account of a constant rise in the medical tourism industry and proactive role adopted by the government in providing huge funds to hospitals to purchase large quantities of mechanical ventilators for their intensive care units.

Medical device manufacturers actively engaged in the production of medical mechanical ventilators are GE Healthcare, Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA., Medtronic, plc., Getinge AB, Smiths Medical, ResMed, Inc., Teleflex Incorporated, Becton Dickinson & Company, and Carl Reiner GmbH.

Key Market Movements:

  • Rising prevalence of chronic lung disease worldwide
  • Increasing growth in the point of care centers will further increase the demand for mechanical ventilators
  • Pandemic outbreaks cause the need for mechanical ventilators to stabilize patient health conditions

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Ketotifen Fumarate Market is expected to grow at a CAGR of 2.9% from 2020 to 2027

As per the latest information brought forward by the World Health Organization (WHO) each year approximately 250,000 deaths related to asthma are reported worldwide. Ketotifen fumarate is ketotifen is a selective, non-competitive H1 receptor antagonist and mast cell stabilizer which is frequently used for the treatment of various kinds of allergic reactions.

As per the latest statistics brought forward by the Global Asthma Report 2018, asthma causes the death of 1000 people every day and approximately affects 339 million people worldwide. Currently Atopic asthma is dominating the indication segment for ketotifen fumarate market growth. Pediatricians use it more frequently as a prophylactic agent in children for the treatment of atopic asthma as it is a basophil and mast cell stabilizer and a potent H1 receptor antagonist. It is anticipated that the allergic seasonal conjunctivitis is set to register excellent market growth owing to the constant rise in the air and water pollution and allergens which are the primary causative agent for the clinical manifestation of allergic seasonal conjunctivitis. The availability of different ophthalmic solutions as generic and OTC products further buttress its market growth.

Browse the full report Ketotifen Fumarate Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/ketotifen-fumarate-market

Hospital pharmacy is presently ruling the distribution channel segment for the ketotifen fumarate market. The capability to perform precise compounding of different dosage and formulation of ketotifen fumarate to treat various allergic reactions overcomes the possibility of adverse drug reaction owing to overdose toxicity. Retail pharmacy is on a rise in the developing regions on account of the establishment of burgeoning generic market and availability of ketotifen fumarate formulations as over the counter products (OTC) products.

North America is presently the highest shareholder in the geography segment for the ketotifen fumarate market. The major contributing factors responsible for its magnificent market growth are rising prevalence of allergic reactions, as per the research citings brought forward by the American Academy of Allergy Asthma & Immunology (AAAAI) approximately 50 million Americans are suffering from some form of allergic disease. Domicile of key players such as Allergan, Plc., Apotex, Corp., Novartis Pharma AG, etc further consolidates its market growth in the region. The market growth in Europe is primarily determined by the rising prevalence of allergic asthma, according to the statistics provided by the European Respiratory Society (ERS) approximately 30 million adults and children in the European region are suffering from allergic asthma. Asia Pacific is keen to register faster market growth during the forecast period on account of the presence of a huge generic market and rising incidence of allergic seasonal conjunctivitis due to dust, pollutants, pollen, and animal dander.

Pharmaceutical companies actively engaged in the manufacturing of the ketotifen fumarate market are Bausch & Lomb, Allergan, Plc., Apotex Corp., Novartis Pharma AG., Alcon Laboratories, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thea Laboratories, Cadila Healthcare, and Mylan Labs Ltd.

Market Key Takeaways:

  • Rising prevalence of allergic reactions on account of increasing pollution, allergens, dust and animal dander
  • Availability of different formulations of ketotifen fumarate as generic versions and OTC products
  • Supportive regulatory environment for the sale and distribution of ketotifen fumarate formulations across the globe

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Orthopedic Electrosurgical Units Market is Expected to Grow at a CAGR of 5.2% from 2020 to 2027

The principle associated with electrosurgery is that the patient is connected with the device by 2 electrodes, and an electric voltage is created between the electrodes by the device. In electrosurgery, the heating is endogenous which is generated by the flow of current in the tissues. The distribution and quantity of released heat are determined by the tissue resistance, voltage, and the geometry of the current path.

Monopolar electrosurgical units are reigning the types segment in the orthopedics electrosurgical units market. They exhibit tremendous versatility in performing modalities such as cut, desiccation, blend, and fulguration, etc. The Monopolar pencil is very frequently used in performing joint surgeries owing to its precision to achieve desired tissue cut and coagulate bleeding. Bipolar electrosurgical units will be registering comfortable market growth during the forecast period. Magnificent ergonomic features such as superior control provided by the forceps electrodes reduce damage to surrounding sensitive tissues and minimize patient burns significantly.

Browse the full report Orthopedic Electrosurgical Units Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/orthopedics-electrosurgical-units-market

Hospitals and clinics are dominating the end-users segment for orthopedics electrosurgical units market. Increasing demand for minimally invasive surgical procedures primarily drives its market growth. Huge funding provided by government healthcare agencies to develop operating units in hospitals further increases the demand for orthopedic electrosurgical units. Ambulatory surgical centers have gained immense popularity in the last 2 decades on account of its ability to provide immediate medical assistance to patients suffering from trauma and fatal vehicle accidents on roadways.

North America is presently leading the geography segment for the orthopedics electrosurgical units market. A constant rise in traumatic and vehicle accidents primarily drives the market growth in the region. According to the latest statistics provided by the National Institute of Health (NIH), approximately 44 million U.S. citizens are suffering from osteoporosis. Furthermore, the presence of major players such as Medtronic, Plc., EndoMed Systems, Bovie Medical Corporation, CONMED Corporation, etc. will further accentuate the market growth in the region. Europe is the second-largest market in the regional segment for the orthopedic electrosurgical units market. According to the statistics presented by the World Health Organization (WHO) in the European Union region, the trauma of limbs requiring surgical interventions due to falls, vehicle accidents, and occupational hazards are 50%, 20%, and 15% respectively. Asia Pacific is anticipated to grow at a faster rate during the forecast period on account of developing healthcare infrastructure and constantly growing medical tourism industry.

Medical device companies actively engaged in providing orthopedic electrosurgical units market are Medtronic, Plc., EndoMed Systems, Dixion Sales Medical Equipment GmbH, Chengdu Mechan Electronic Technology Co., Ltd., Erbe Elektromedizin GmbH, Bovie Medical Corporation, B. Braun Melsungen AG., CONMED Corporation., Q Medical, and BOWA-electronic GmbH & Co. KG.

Market Key Takeaways:

  • Rising prevalence of musculoskeletal disorders requiring surgical intervention as a treatment option worldwide
  • Increasing demand for minimally invasive surgical procedures increases the demand for orthopedics surgical units
  • Technological advancement in the electrosurgical units bolster the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Levobupivacaine Market is expected to grow at a CAGR of 3.5% from 2020 to 2027

Levobupivacaine is a long-acting local anesthetic agent belonging to the amido amine group, it is basically an S-enantiomer of bupivacaine drug. It has become popular among anesthesiologists worldwide owing to its less cardiotoxicity and motor blockade. It was primarily developed due to the reported incidents of seizures and cardiac arrests experienced due to the use of intravenous injection of bupivacaine. Significant rise in surgeries performed and increasing demand for post-operative pain management drive the levobupivacaine market growth.

Epidural anesthesia is currently representing the largest market share in the levobupivacaine market. The major features which are responsible for its market dominance are a significant rise in the labor pain experience during livebirths. It is the most preferred local anesthetic for epidural anesthesia during live births to obtain pain relief to the mothers experiencing labor pain. The amount of anesthetic agent delivered can be adjusted in epidural anesthesia depending upon the intensity of pain experienced by the mother during labor. Spinal anesthesia are is required for surgeries that are performed below the umbilicus such as orthopedic surgery of the hip, pelvis, knee, and vascular surgeries of the legs. Peripheral nerve blocks are anticipated to gain huge traction during the forecast period owing to the significant rise in the number of fatal accidents inflicting grievous injuries to victims and increasing demand for postoperative pain management.

Browse the full report Levobupivacaine Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/levobupivacaine-market

Hospital pharmacy is currently spearheading the end-user segment for the levobupivacaine market. The inherent features such as immaculate compounding of local anesthetic drugs and the ability to cater to the medical needs of patients 24/7 primarily determine its market growth. Retail pharmacy is constantly increasing in numbers in the developing regions on account of the existence of a huge generic market and provisions of medicines at a discounted rate.

North America is dominating the geography segment for levobupivacaine market. A significant rise in the number of surgeries performed and effective implementation of guidelines pertaining to pain management therapy primarily determines the levobupivacaine market growth. Additionally, the favorable reimbursement scenario associated with the use of levobupivacaine during surgical procedures further accentuates its market growth in the region. Europe is in the 2nd place in the geography segment for levobupivacaine market. The constant rise in the dental and cosmetic surgeries performed increases the demand for levobupivacaine as a local anesthetic agent in the European Union region. Asia Pacific is set to embark on impressive market growth in the near future on account of the growing medical tourism industry and developing healthcare infrastructure.

Pharmaceutical companies actively engaged in the manufacturing of levobupivacaine are AbbVie, Inc., Fresenius Kabi, Altan Pharma, AstraZeneca, Plc., Maruishi Pharmaceutical Co., Ltd., Hengrui Therapeutics, Inc., Cristália, Pharos Ltd., Yangzhou Tianhe Pharmaceutical and Ropsohn Therapeutics.

Market Key Takeaways:

  • Constantly increasing number of surgical procedures and labor pain experienced with livebirths worldwide
  • Excellent pharmacodynamic and pharmacokinetic drug profile renders it safe and efficacious in comparison to ropivacaine and bupivacaine
  • Affordable reimbursement scenario associated with the use of levobupivacaine in surgical procedures

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Flecainide Market is expected to grow at a CAGR of 3.2% from 2020 to 2027

Flecainide is classified as a class 1 antiarrhythmic drug which received USFDA approval in 1985 for the treatment of atrial fibrillation and ventricular tachycardia. It causes the inhibition of the sodium and potassium ion channels in the heart causing an increase in the heart threshold for depolarization and correcting arrhythmias. It is available in doses of 50,100 and 150mg tablets for the treatment of different severity of cardiac arrhythmias.

Supraventricular tachycardia is presently leading the indication segment for the flecainide market. The chief causative agents for its clinical manifestations are preexisting heart failure complications and congenital heart disease. Paroxysmal supraventricular is most commonly found in the women and older adults population throughout the globe. Atrial Fibrillation is caused by factors such as hypertension, coronary artery disease and lung diseases. As per the World Health Organization (WHO), in 2017 approximately 3.046 million new cases were reported to be suffering from atrial fibrillation. Wolff-Parkinson-White Syndrome is anticipated to register rampant market growth during the forecast period on account of a constant rise in the newborn suffering with Ebstein anomaly which is manifested by the structural defect of the tricuspid valve which allows the blood to flow from the right atrium to right ventricles.

Browse the full report Flecainide Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/flecainide-market

Hospital pharmacy is spearheading the end-user segment for the flecainide market. The major features which attributes to its superior market growth are the availability of skilled pharmacist to compound different doses of flecainide for patients suffering from different severity of cardiac arrhythmias. Retail pharmacy is gaining huge prominence in the developing regions owing to the ever-increasing generic market and capability to provide medical needs of cardiac patients residing in the remote locations.

North America is representing the largest market in the geography segment for the flecainide market. As per the latest research citings presented by the Center for Disease Control and Prevention (CDC), in 2017 atrial fibrillation was responsible for the deaths of 166,793 U.S. citizens. Furthermore effective implementation of treatment guidelines pertaining to cardiovascular complications and affordable reimbursement scenario for flecainide used in the treatment of heart diseases further buttresses the flecainide market growth in the region. Europe is in the 2nd position in the geography segment on account of the constantly growing generic market for flecainide and recommendation of European Medical Agency (EMA) to use flecainide as the first-line therapy for paroxysmal supraventricular tachycardia in elderly patients. Asia Pacific is set to witness lucrative market growth on account of developing healthcare infrastructure and a significant rise in the medical tourism industry.

Pharmaceutical companies actively engaged in the manufacturing of flecainide are Mylan Labs Ltd., Aurobindo Pharma, Amneal Pharmaceuticals, LLC., Sun Pharmaceutical Industries Ltd., Apotex, Inc., Bausch Health, AvKARE, Inc., Eisai Co., Ltd., ANI Pharmaceuticals and InCarda Therapeutics, Inc.

Market Key Takeaways:

  • The constant rise in the number of patients suffering from supraventricular tachycardia and atrial fibrillation
  • Effective implementation of treatment guidelines pertaining to cardiovascular complications to drive flecainide market
  • Affordable reimbursement scenario and the existence of well-developed generic market to further propel the flecainide market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Medical Isolation Eye Masks Market is expected to grow at a CAGR of 8.3% from 2020 to 2027

The primary objective of medical isolation eye masks or shields is the protection of the mucous membranes of the eye region from sprays, splashes, and spatter of body fluids, it is used together with other personal protective equipment.

Surgical procedures are representing the largest market share in the application segment for the medical isolation eye masks market. According to the latest information provided by the World Health Organization (WHO), the global surgical rate is estimated to be 4,469 operations per 100,000 people per year. Increasing demand for surgical interventions throughout the globe as a treatment option for lifestyle disorders such as cardiovascular disease, gastrointestinal disorders, pulmonary complications, etc. Screening go biological samples is estimated to showcase excellent market growth in the near future owing to the rising public health awareness resulting in early screening and diagnosis of infectious diseases. Constantly growing life sciences segment diligently working to build immunity against fatal infectious diseases increases the demand for medical isolation eye masks.

Browse the full report Medical Isolation Eye Masks Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/medical-isolation-eye-masks-market

Hospitals & clinics are leading the end-user segment for the medical isolation eye masks market. The chief attribute contributing to its positive market growth is the significant rise in chronic diseases requiring surgical intervention as a treatment option. Ambulatory surgical centers have gained tremendous traction in the last 2 decades owing to a significant increase in outpatient visits due to its ability to reduce the healthcare cost burden. It is crucial in catering medical assistance to patients residing in remote locations.

North America is dominating the geography segment for the medical isolation eye masks market. The constant rise in the number of patients suffering from lifestyle disorders requiring surgical intervention as a treatment option. Recent information provided by the National Hospital Ambulatory Medical Care Survey (NHAMCS), annually,28.6 million U.S. citizens visit to perform surgical procedures to both hospitals and ASC combined. The presence of key players Medline Industries, Inc., McKesson Corporation, Halyard Health, Prestige Ameritech, etc. further accentuates the market growth in the region. Europe is the second-largest regional market for the medical isolation eye masks market. A strategic partnership between government healthcare agencies and pharmaceutical firms in the development of novel vaccines and drugs to curb the mortality rate associated with fatal infectious disease. Asia Pacific is anticipated to register comfortable market growth during the forecast period on account of rising public health awareness resulting in early screening of virulent infections and flourishing life sciences industry.

Medical devices companies actively engaged in providing medicines for the treatment of Medical Isolation Eye Masks are Medline Industries, Inc., McKesson Corporation, Halyard Health, S2S GLOBAL, 3M Healthcare, Yanming Global, AVI Global Plast., Alpha Pro Tech, Ltd., Prestige Ameritech, and Sanax Protective Products.

Market Key Takeaways:

  • Significant increase in the number of surgical procedures performed worldwide
  • Increasing public health awareness resulting in early screening of fatal infectious diseases
  • Supportive role adopted by the global healthcare regulatory agencies in  promoting the sale and distribution of medical isolation eye masks market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Protective Surgical Gowns Market Is Expected to Grow At A CAGR of 6.2% from 2020 to 2027

Protective surgical gowns are classified as a Class II medical device which requires a 510(k) premarket notification by the USFDA. The manufactures are engaged in the production of protective surgical gowns on the basis of its use as per the AAMI classification of 1-4 risk levels.

Disposable gowns are representing the largest market share in the type segment for the protective surgical gowns market. The ergonomic features associated with disposable protective surgical gowns are cost-effectiveness and high safety assurance, there is no extra cost incurred for bleaching, disinfecting and conditioning, etc. Manufacturers are producing disposable protective surgical gowns that are made from hypoallergenic material which provides maximum safety from biohazard exposure. The looming threat of hospital-acquired infections (HAI’s) and the growing incidence of microbial resistance further propel market growth. Reusable surgical gowns are expected to showcase appreciable market growth in the near future owing to its increasing demand in the pharmaceutical industry and academic research institutes worldwide. Medical grade fabric is being utilized in the manufacturing of reusable protective surgical gloves which has high fluid resistance, provides maximum protection form biohazard exposure, and stain free. Regular autoclaving and washing with disinfectant renders it clean and safe for recurrent use.

Browse the full report Protective Surgical Gowns Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/protective-surgical-gowns-market

Hospitals & clinics are currently leading the end-user segment for the protective surgical grounds market. Spreading of viral infections worldwide at an alarming rate creates the requirement of immediate screening of susceptible patients at government-sponsored hospitals and clinics. A constant rise in the surgical procedures opted by the patients for the treatment of chronic diseases worldwide further accentuates the market growth. Ambulatory surgical centers are anticipated to register rampant market growth on account of its ability to provide emergency medical services to injured people on highways and remote locations.

North America is presently dominating the geography segment for the protective surgical gowns market. A significant increase in the research and development activities in the life sciences segment primarily drives the market growth in the region. The existence of developed healthcare infrastructure further accentuates the protective surgical gown’s market growth. The presence of key players such as Halyard Health, 3M Company, Medline Industries, Inc., Cardinal Health, etc. will further bolster the market growth in the region. Europe is the second-largest regional segment owing to the significant increase in the number of surgical procedures performed in the region. The Asia Pacific is anticipated to be the fastest market growth during the forecast period on account of the developing healthcare infrastructure and lucrative market opportunities for western giants to establish retail outlets and subsidiaries in the Asia Pacific.

Surgical products manufacturers actively engaged in the production of protective surgical gowns are Mölnlycke Health Care AB, Halyard Health (Owens & Minor), 3M Company, Medline Industries, Inc., Vygon S.A., Cardinal Health, Lohmann & Rauscher GmbH & Co. KG., Ahlstrom-Munksjö, PRIMED Medical Products, Inc., and Priontex (PTY) LTD.

Key Market Movements:

  • Significant increase in the number of surgical procedures performed worldwide
  • Spreading of infectious diseases across the globe at an alarming rate creates the need for effective screening and treatment thereby increasing the demand for protective surgical gowns
  • Continuous growth in the research and development activities in the life sciences sector to provide excellent healthcare facilities further accentuate the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Swine Epidemic Diarrhea Vaccines Market Is Expected to Grow At A CAGR of 6.9% from 2020 to 2027

Porcine epidemic diarrhea virus is a large RNA enveloped virus which belongs to the Alphacoronavirus within the Coronaviridae. Highly virulent in its nature has an 80 to 100% mortality rate in neonatal pigs which causes huge economic burden to breeders and farmers across the globe. The current position is that very few players are active in the market which provides a tremendous opportunity for biopharmaceutical players engaged in veterinary health.

Killed vaccines are representing the largest market share in the type segment for swine epidemic diarrhea vaccines market. The killed vaccines are beneficial in prefarrowing vaccination of the healthy pregnant sows and gilts against the diarrheal disease occurring in the neonatal pigs. The vaccine also has an adjuvant which helps in improving the immune response. Live vaccines are anticipated to register marvelous market growth in the near future as the live attenuated vaccines multiply quickly in the pigs thereby providing a big antigenic stimulus ensuring long-lasting immunity in the adult pigs.

Browse the full report Swine Epidemic Diarrhea Vaccines Market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/swine-epidemic-diarrhea-vaccines-market

Neonatal pigs are dominating the application segment for swine epidemic diarrhea vaccines market. According to the latest research citings presented by the Vaccine and Infectious Disease Organization (VIDO) of Canada the PEDV Type II strain is highly virulent in the neonatal pigs resulting in a 100% mortality rate due to watery diarrhea and dehydration. Adult pigs are anticipated to register sturdy market growth during the forecast period on account of the increasing incidence of PEDv Type I infection in the adult pigs. Increasing demand for pork meat worldwide will further determine the swine epidemic vaccines market growth.

North America is currently leading the geography segment for swine epidemic diarrhea vaccines market. The growing incidence of PEDV Type 1 infection in the pig farms primarily drives the market growth in the region. Increasing public health awareness among farmers and breeders regarding the economic burden cost by the spread of this virulent PEDV infection among the swine population in the region. Europe is considered the second-largest regional segment due to the supportive regulatory environment provided by the healthcare agencies for the development and early clearance of PEDV vaccine in the region. The Asia Pacific is anticipated to register the fastest market growth in the regional segment for swine epidemic diarrhea vaccines market. Increasing demand for pork meat in the South East Asia region primarily drives the market growth in the region.

Biopharmaceutical manufacturers actively engaged in the production of swine epidemic diarrhea vaccines are CAVAC, Intervet, Inc. (Merck & Co., Inc.), Zoetis Services, LLC, Nisseiken Co., Ltd., Komipharm international co. ltd. and Green Cross Veterinary Products.

Key Market Movements:

  • Growing incidence of porcine epidemic diarrhea viral infection among the swine population worldwide
  • Increasing research and development activities conducted in the biopharmaceutical industries to develop live attenuate vaccines to treat PEDV infection
  • Supportive regulatory environment provided by the government healthcare agencies to provide early clearance for the use of PEDV vaccines in the pig farms throughout the globe

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Doxylamine Market is expected to grow at a CAGR of 2.4% from 2020 to 2027

Doxylamine is a first-generation antihistamine that is available either as a prescribed drug or over the counter product for the treatment of insomnia, allergic rhinitis, and nausea & vomiting in pregnancy.

Sleep aid is reigning the clinical application segment for the doxylamine market. As per the latest research citings presented by the World Health Organization (WHO), nearly 50% of the adult population above 60 years of age suffer from insomnia worldwide. The recommended dose of doxylamine succinate tablets is 25mg orally every evening 30 minutes before bedtime. According to the statistics provided by the American Academy of Allergy, Asthma & Immunology (AAAAI), approximately 40% of the world population has sensitization of IgE antibodies to allergens present in the environment. Doxylamine is used in combination with dextromethorphan hydrobromide or phenylephrine hydrochloride to treat allergic infections of the respiratory tract. Nausea and vomiting in pregnancy are anticipated to register rampant market growth during the forecast period because 50% of women encounter nausea and vomiting during pregnancies.

Browse the full report Doxylamine Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/doxylamine-market

Hospital pharmacy is leading the distribution channel segment for the Doxylamine market. Doxylamine has potent sedative properties which might lead to drug addiction in insomnia patients constantly seeking access to medicine to induce sleep on a regular basis. Hospital pharmacist ensures precise dispensing of the doxylamine drug posology in accordance with a doctor’s prescription. Retail pharmacy is gaining positive growth traction in the developing countries owing to the presence of flourishing generic drugs market and availability of doxylamine with different drug combination as an over the counter product.

North America is currently leading the geography segment for the doxylamine market.  As per the latest research citings presented by the National Institute of Health (NIH), approximately 60 million Americans are suffering from insomnia. A significant increase in allergic rhinitis infections further accentuates the doxylamine market growth. Domicile of major players such asL. Perrigo Company, Apotex Corporation, BJWC, etc., bolster the doxylamine market growth in the region. Europe is the second-largest market in the regional segment for the doxylamine market. The growing incidence of hyperemesis gravidarum in pregnant women in the European Union region chiefly supports the doxylamine market growth in the region. The supportive regulatory environment provided by the European Medical Agency (EMA) for the sale and distribution of doxylamine strengthens the market growth in the region. Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period. The constant rise of short term insomnia in patients suffering from depression and constant growth observed in the generic drugs market.

Pharmaceutical companies actively engaged in the production of doxylamine are L. Perrigo Company, Apotex Corporation, BJWC, Teva Pharmaceutical Industries Ltd., Mylan Pharmaceutical Industries Ltd., Chattem, Inc., Duchesnay USA, Inc., Alliance Pharmaceuticals Limited., Pfizer Consumer Healthcare and Poly Pharmaceuticals, Inc.

Market Key Takeaways:

  • Significant increase in the number of patients suffering from short term insomnia worldwide
  • Rising prevalence of patients suffering from allergic infections of the respiratory tract
  • Availability of over the counter products containing doxylamine in developed countries and flourishing generic drugs market together drive the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Aclidinium Bromide Market Is Expected To Grow At A CAGR of 4.1% From 2020 To 2027

Aclidinium bromide is classified as a long-acting inhaled muscarinic antagonist that is prescribed for the long term maintenance treatment of chronic obstructive pulmonary disorders such as chronic bronchitis and emphysema. The constant rise in air pollution and cigarette smokers together drive the aclidinium bromide market growth.

Aclidinium Bromide 400mcg/Actuation is reigning the formulation segment for the aclidinium bromide market. It is generally prescribed for the long term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disorder (COPD). The recommended dose is 400mcg/actuation twice daily usually available in a multi-dose device as a dry powder inhaler which is metering 400mcg of aclidinium bromide per actuation. The combination formulation of Aclidinium Bromide 400mcg + Formoterol Fumarate 12mcg/Actuation is anticipated to register magnificent market growth during the forecast period owing to its therapeutic efficacy to provide relief from the symptoms associated with COPD. Clinical trial studies have reported that combination formulation reduces major cardiovascular adverse effects by 22% in comparison to aclidinium bromide as a single formulation.

Browse the full report Aclidinium Bromide Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/aclidinium-bromide-market

Hospital Pharmacy is currently leading the end-user segment for the aclidinium bromide market. The chief attributing factors responsible for its market dominance are the presence of skilled pharmacist to precisely compound the aclidinium bromide inhaler formulation as a drug powder to negate any possibility of fatal overdose toxicity. Retail pharmacy is gaining huge demand in the developing regions owing to its ability to provide middle and low-income customers with the aclidinium bromide inhalers at discounted prices.

North America is spearheading the geography segment for aclidinium bromide market. As per the statistics brought forward by the Center for Disease Control and Prevention (CDC), about 16 million U.S. adult citizens were reported to be suffering from COPD. Existence of developed healthcare infrastructure and domicile of key players such as AstraZeneca, AB., Circassia Pharmaceuticals, Inc., Allergan, Plc., further buttress the market growth in the region. Europe is placed in the second position on account of the affordable reimbursement scenario for the aclidinium bromide formulations used for the treatment of bronchospasm in chronic bronchitis and emphysema patients in the European Union. It is expected that the Asia Pacific is keen to register magnificent market growth during the forecast period on account of the rising prevalence of pulmonary disorders owing to rising air pollution and a significant increase in the number of cigarette smokers.

Pharmaceutical companies actively engaged in the manufacturing of aclidinium bromide are AstraZeneca, AB., Circassia Pharmaceutical Inc., Allergan, Plc., Daewoong Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Menarini Group, Eisai Pharmaceuticals, and Industrias Farmaceuticas Almirall S.A.

Market Key Takeaways:

  • Rising prevalence of chronic obstructive pulmonary disorder due to the constant rise in air pollution and cigarette smokers worldwide
  • Technological advancement in the aclidinium bromide inhaler formulation to provide immediate relief to patients suffering from chronic bronchitis and emphysema
  • Affordable reimbursement scenario for the aclidinium bromide formulation used for the treatment of pulmonary disorders

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Allergy Immunotherapy Market Is Expected to Grow At A CAGR of 9.8% from 2020 to 2027

As per the latest research citings provided by the World Health Organization (WHO), approximately 300 million people worldwide are suffering from asthma. Rising public health awareness regarding the therapeutic efficacy and safety associated with allergy immunotherapy will further accentuate its market growth.

Subcutaneous immunotherapy is leading the treatment segment for allergy immunotherapy market. Subcutaneous injections are beneficial in achieving desired immunomodulation via 2 steps which are buildup phase which ranges from 3 to 6 months and then the maintenance phase which ranges from 2 to 4 weeks. They are manufacturers in standard doses similar to regular vaccines. Sublingual immunotherapy is anticipated to register rampant market growth during the forecast period on account of its enhanced therapeutic efficacy for seasonal allergies. Researchers are working diligently in the manufacturing of sublingual tablets which has a fast onset of action in allergic reactions induced by pollen, ragweed, dust, and mites, etc.

Browse the full report Allergy Immunotherapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/allergen-immunotherapy-market

Hospital pharmacy is presently spearheading the distribution channel segment for allergy immunotherapy market. The onset of action is immediate with allergy immunotherapy, hence it is necessary for the patients to do get the medicines accurately dispensed from the hospital pharmacist to negate the occurrence of any fatal health issues. Retail pharmacy is going to register magnificent market growth I the developing regions on account of availability of government-subsidized essential medicines at lower prices and increasing trend of chain pharmacies with major business houses investing huge funds in entering the retail pharmacy segment.

Europe is currently dominating the geography segment for allergy immunotherapy market. A significant increase in the number of asthma cases induced due to allergic reactions primarily drives the market growth in the region. As per the latest research citings provided by the European Academy of Allergy and Clinical Immunology (EAACI), approximately 10 million of the European population is suffering from asthma induced by allergic reactions. Further clinical studies have indicated enhanced sensitivity among Caucasians for immunoglobulin E mediated anaphylactic shock reactions. Domicile of key players such as ALK-Abelló A/S, LETI Pharma, Anergis SA, Biomay AG, etc. further accentuates the market growth in the region. North America is placed in the second position in the regional segment for allergic immunotherapy market. Strategic collaboration between academic research institutes and pharmaceutical players for the development of allergy immunotherapy drives the market growth in the region. Asia Pacific is anticipated to register the fastest market growth in the regional segment. Rapid has given rise to the occurrence of allergic reactions due to water and air pollutions which causes eczema and asthma respectively. Rising public health awareness regarding the benefits of allergic immunotherapy will further accentuate the market growth in the region.

Pharmaceutical manufacturers actively engaged in the production of allergy immunotherapy are Stallergenes Greer Ltd., ALK-Abelló A/S., Merck KGaA., Allergy Therapeutics, Plc., Holister Stier (Jubilant Pharma Company), Biomay AG, LETI Pharma, Anergis SA., DBV Technologies and Circassia Pharmaceuticals.

Key Market Movements:

  • Rising prevalence of allergic reactions worldwide
  • Increasing public health awareness regarding benefits of allergic immunotherapy
  • The supportive regulatory environment provided by the global healthcare agencies for the growth of allergic immunotherapy

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Albendazole Veterinary Drugs Market Is Expected To Grow At A CAGR Of 3.6% From 2020 To 2027

Albendazole is a broad-spectrum anthelmintic drug that is frequently used for the treatment of helminthiasis in the animal population throughout the globe. It usually exerts its pharmacodynamics effect by inhibiting the polymerization of tubulin causing loss of cytoplasmic microtubules. This eventually depletes the energy production of the parasite causing immobilization and death of the parasite.

Roundworms are currently representing the largest market share in the vector segment for the albendazole veterinary drugs market. The most common type of roundworm entering into the gastrointestinal tract of the grazing animals is the soil-transmitted schistosomiasis and ascariasis. The dose of albendazole for the treatment of helminthiasis in farm animals is adjusted at 7.5 to 10mg/kg for large cattle and for sheep and goats the dose is adjusted at 5mg/kg. Tapeworms enter through the oral route of the pet animals such as cats and dogs by the intake of contaminated food, water, ingested fleas, etc. The most frequently occurring tapeworms in the pet animals are Dipylidium caninum and taenia taeniaeformis in dogs and cats respectively. The dose of albendazole for the treatment of helminthiasis infection in pet animals is adjusted at 10, 25, or 50mg/kg according to the severity and type of helminthiasis infection.

Browse the full report Albendazole Veterinary Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/albendazole-veterinary-drugs-market

Farm animals are spearheading the animal types segment for the albendazole veterinary drugs market. The rising incidence of helminthiasis infection and increasing demand for protein-based meat and dairy products increases the demand for albendazole veterinary drugs market. The pet animals are keen to register faster market growth during the forecast period owing to the rising adoption of pet animals and increasing public animal health awareness.

North America is currently leading the geography segment for the albendazole veterinary drugs market. The rising prevalence of helminthiasis infection in the farm animals primarily determines its market growth. Increasing demand for protein-based meat and dairy products further increases the demand for albendazole for treating parasitic infections in farm animals. Domicile of major players such as Zoetis, Inc., Virbac and MSD Animal Health, etc. further buttress the albendazole veterinary drugs market growth in the region. Europe is placed in the 2nd place on account of stringent regulatory norms implemented by the European Medical Agency (EMA) in order to prevent the outbreak of the zoonotic disease in the region. The Asia Pacific is set to register impressive market growth during the forecast period owing to the increasing adoption of pet animals and increasing public animal health awareness.

Pharmaceutical companies engaged in the manufacturing of albendazole veterinary drugs are Bova, GlaxoSmithKline, Plc., Johnson & Johnson, Mankind Pharma, Ceva Santé Animale, Virbac, Zoetis, Inc., Sanofi-Aventis Farmaceutica Ltda, MSD Animal Health and LAFEDAR Laboratories S.A.

Key Market Movements:

  •    Rising prevalence of helminthiasis infection in the animal population worldwide
  •   Significant rise in pet adoption and increasing public animal health awareness in the developing nations
  •   Stringent norms implemented by healthcare regulatory agencies pertaining to the prevention of the spread of zoonotic diseases

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Report Market Reports

Global Amdinocillin Market Is Expected To Grow At A CAGR Of 3.0% From 2020 To 2027

Amdinocillin has broad-spectrum activity against infections caused due to gram-negative bacteria. The oral bioavailability of amdinocillin is very low hence its prodrug pivmecillinam is prescribed for treatment of urinary tract infection, typhoid, pyelonephritis, etc.

Urinary tract infections are leading the treatment segment for the amdinocillin market. It is usually caused by gram-negative bacteria such as E.coli, Klebsiella, Candida, Proteus, etc. In younger women increased sexual activity is the chief causative agent for the recurrence of UTI after 6 months, in postmenopausal women the risk factor associated with urinary tract infections is diabetes mellitus, history of antibiotics use, residential status, etc. Typhoid fever is endemic to South Asian countries, 80% of the cases are reported from India, Pakistan, Bangladesh, China, Indonesia, Vietnam, etc. According to the research findings provided by the World Health Organization (WHO), it is estimated that 200,000 people die annually worldwide due to typhoid. The other treatment segment is anticipated to be the fastest-growing segment in the near future on account of promising clinical trial studies pertaining to the therapeutic efficacy and safety of amdinocillin in the treatment of pyelonephritis.

Browse the full report Amdinocillin Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/amdinocillin-market

Hospital pharmacy is spearheading the distribution channel segment for the amdinocillin market. Amdinocillin is penicillin antibiotic-associated with serious drug-related side effects such as skin rashes, nausea, vomiting, etc., hence hospital pharmacists adhere to accurate drug compounding in cognizance to physician’s prescription. Retail pharmacy is gaining huge popularity in developing countries on account of flourishing generic drugs market and proactive government intervention in establishing generic retail pharmacy stores to provide medicines at low cost to the poor and needy patients.

Europe is presently dominating the geography segment for the amdinocillin market. According to the latest statistics presented by the National Institute of Health (NIH), the prevalence rate of HAUTI in the Europe region is 19.6%, it has a high incidence rate in the Scandinavian countries. Furthermore, an affordable reimbursement scenario and proactive role adopted by the European Medical Agency (EMA) to evaluate the clinical trial investigation of amdinocillin prodrug in the treatment of pyelonephritis will accentuate the market growth in the region. The market growth in the Asia Pacific region is attributed to key factors such as the rising prevalence of typhoid and the existence of flourishing generic drugs market. North America is anticipated to register rapid market growth during the forecast period because recently the USFDA has granted Qualified Infectious Disease Product (QIDP) designation to amdinocillin for the treatment of complicated urinary tract infection prevalence in the region.

Pharmaceutical companies actively engaged in the manufacturing of amdinocillin are Leo Pharma AB, Knight Therapeutics Inc., Cayman Chemical Company, Utility Therapeutics, Ltd, Karo Pharma AB, Aurobindo Pharma Limited, Takeda Pharmaceutical Company Limited, Orion Pharma AB, Aristopharma Ltd, and Merck KGaA.

Market Key Takeaways:

  • Significant increase in the number of cases of complicated urinary tract infection worldwide
  • Affordable reimbursement scenario for amdinocillin drug formulation used in the treatment of infection’s associated with gram-negative bacteria
  • The supportive regulatory environment provided by the global healthcare agencies for the sale and distribution of amdinocillin drug formulation

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Sivelestat Sodium Market Is Expected To Grow At A CAGR Of 4.6% From 2020 To 2027

Sivelestat sodium is a competitive inhibitor of neutrophil elastase, it was used as a drug candidate during the severe acute respiratory syndrome (SARS) epidemic which occurred in China in 2003. Many pharmaceutical companies did not proceed with the clinical trials back then as the SARS epidemic was over. Recently it came to cognizance after the National Medical Products Administration of China (NMPA), has given approval for the use of sivelestat sodium in the treatment of COVID-19 infection.

Acute lung injury is reigning the treatment segment for the sivelestat sodium market. The key attributes responsible for the disease prognosis of acute respiratory distress syndrome are aspiration, pneumonia, and extrapulmonary sepsis, etc. The clinical manifestations associated with the disease are refractory hypoxemia, accumulation of pulmonary edema which decreases the lung’s capacity in eliminating carbon dioxide. It is still the most undertreated medical condition which has a mortality rate of 40%. Pediatric cardiopulmonary bypass surgery is anticipated to be the fastest-growing treatment segment on account of the ability of sivelestat sodium in reducing the perioperative inflammatory response and drastically reduces the duration of mechanical ventilation.

Browse the full report Sivelestat Sodium Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/sivelestat-sodium-market

Hospitals and clinics are spearheading the end-user segment for the sivelestat sodium market. Patients throughout the globe suffering from acute respiratory distress syndrome are immediately hospitalized in the critical care units of hospitals and clinics to stabilize the medical condition by mechanical ventilation. Ambulatory surgical centers will be registering lucrative market growth during the forecast period owing to its ability to serve patients residing in remote locations.

Asia Pacific is dominating the geography segment for the sivelestat sodium market. Rising prevalence of acute respiratory distress syndrome (ARDS), the major countries contributing to its supreme epidemiological count is Japan, China South Korea, etc. As per recent statistics provided by the World Health Organization (WHO), the annual incidence rate of acute respiratory distress syndrome in the Asia Pacific region is 15.19 per 100,000 people. Additionally, the presence of major players such as Ono Pharmaceutical Co., Ltd, Teva Takeda Yakuhin Ltd, and Shanghai Huilun Jiangsu Pharmaceutical Co. Ltd, etc. fortify the market growth in the region. Europe is the second-largest market on account of the rising prevalence of aspiration induced acute lung injury in the European Union region. Proactive role adopted by the European Medical Agency (EMA) to conduct clinical trial investigation pertaining to the therapeutic efficacy and safety of sivelestat sodium in curbing the High mortality rate associated with COVID -19 infection. North America will be the fastest-growing regional segment in the near future owing to the rising prevalence of acute lung failure. According to the recent facts provided by the American Journal of Respiratory and Critical Care Medicine annually in the United States 190,600 cases of acute respiratory distress syndrome are reported.

Pharmaceutical companies actively engaged in the production of sivelestat sodium are Merck KGaA., Enzo Life Sciences, Inc., Ono Pharmaceutical Co., Ltd., Teva Takeda Yakuhin Ltd., Tocris Bioscience, Cayman Chemical, Shanghai Huilun Jiangsu Pharmaceutical Co. Ltd., R&D Systems, Inc., Toronto Research Chemicals and Abcam, plc.

Market Key Takeaways:

  • Rising prevalence of acute respiratory distress syndrome worldwide
  • A constant increase in the patients suffering from acute lung injury associated with aspiration, pneumonia and pulmonary sepsis
  • Proactive role adopted by global healthcare agencies in conducting clinical trial studies to investigate the therapeutic efficacy and safety of sivelestat sodium in the treatment of COVID-19 infection

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Hydroxychloroquine Sulfate Tablets Market is expected to grow at a CAGR of 4.7% from 2020 to 2027

Hydroxychloroquine sulfate tablets are enlisted on the World Health Organization (WHO) list of essential medicines. As an antimalarial drug its mechanism of action comprises increasing the lysosomal pH of the antigen-presenting cells. In the treatment of autoimmune diseases such as rheumatoid arthritis and lupus erythematosus it has been reported to block the toll-like receptor signals to reduce the inflammation. Currently it is under investigation for its therapeutic efficacy for the treatment of COVID-19 infection.

Hydroxychloroquine sulfate tablets are still considered as a first-line drug therapy for geographical regions where chloroquine resistance is not reported. The posology associated with malaria treatment is 400mg weekly starting 2 weeks before exposure and is continued for 4 weeks after leaving the endemic area. It is successfully employed as a DMARD medicine for the treatment of rheumatoid arthritis with the dosage of 400-600 mg/day in the BID, used in combination with corticosteroids or salicylates for better results. The drug also finds application in the treatment of lupus erythematosus in which the drug posology is 200mg single dose per day.

Browse the full report Hydrochloroquine Sulfate Tablets Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/hydroxychloroquine-sulfate-tablets-market

Hospital pharmacies are spearheading the end-user segment for hydroxychloroquine sulfate tablets market. It favors the capability of dispensing a different dose of hydroxychloroquine for different age group patients to prevent overdose toxicity which is fatal. Retail pharmacy is quite popular in the developing regions owing to the presence of a huge generic market for hydroxychloroquine sulfate tablets which are sold at cheap price and it caters to the medical needs of patients residing in remote locations.

Middle East and Africa are currently leading the geography segment for hydroxychloroquine sulfate tablets market. The rising prevalence of malarial infection in the sub-Saharan region responsible for 93% of all known mortality associated with malaria causes tremendous demand for hydroxychloroquine which is still used as a first-line drug therapy. The region receives free medical aid from regulatory bodies such as WHO, Red Cross, etc. for the treatment of malarial infection. Latin America represents the second-largest regional market on account of the presence of a large rain forest area which is a teeming growing for malarial infection. Asia Pacific is keen to register impressive market growth during the forecast period on account of the presence of tropical and subtropical climate in SE Asian countries which favors the spread of malaria-infected mosquitos, furthermore, the cheap generic market further propels the hydroxychloroquine sulfate tablets market growth. In developed regions such as North America and Europe it is used for the treatment of autoimmune disease.

Pharmaceutical companies actively engaged in the manufacturing of hydroxychloroquine sulfate tablets are Mylan Labs Ltd., Teva Pharmaceutical Industries Ltd., Sanofi SA., Sandoz, IPCA Laboratories Ltd., Amneal Pharmaceuticals, Inc., Cadila Healthcare, Bristol Laboratories Ltd., AvKARE, Inc. and Covis Pharmaceutcials, Inc.

Market Key Takeaways:

  • Rising prevalence of malaria in the tropical and subtropical regions of the world
  • Therapeutic efficacy of the hydroxychloroquine sulfate in autoimmune diseases such as rheumatoid arthritis and lupus erythematosus further propels its market growth
  • Affordable reimbursement scenario for the hydroxychloroquine sulfate tablets used as a medication

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Umbilical Cord Clamps Market Is Expected To Grow At A CAGR Of 5.2% From 2020 To 2027

Umbilical cord is a gynecological instrument which is used for clamping the umbilical cord after the live birth in order to separate the newborn from the mother’s placenta. Earlier the waiting period before clamping was considered as 1 minute but current guidelines pertaining to obstetrics and gynecology consider 3 to 5 minutes necessary to ensure optimum blood iron level in the newborn.

Stainless steel umbilical cord clamps are frequently used as they are safe to reuse after they have been rendered sterile by autoclaving with other gynecological devices. They are considered as a green alternative to plastic and polymer-based clamps and hence does not require a cutting tool. Polymer-based umbilical cord clamps will be the largest and fastest-growing product segment during the forecast period. Inherent features such as non-toxic, sterile, and pyrogen-free polymers used in manufacturing clamps which are intended for single-purpose thereby drastically reducing the risk of cross-contamination. It ensures protection against accidental reopening, provides excellent angle movement for the clamps which is gaining huge popularity among gynecologists as it is relatively safe to use due to the presence of grooves and notches on the clippings surface which prevents slipping of the umbilical cord and reduces injury.

Browse the full report Umbilical Cord Clamps Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/umbilical-cord-clamps-market

Hospitals are currently spearheading the end-user segment for the umbilical cord clamps market. It is the first point of contact for middle and low-income households seeking midwifery medical services. Clinics are gaining tremendous market growth owing to its ability to provide obstetrics and gynecological services to people inhabiting in remote locations.

North America is currently dominating the geography segment for the umbilical cord clamps market. The primary factor which determines its market dominance is the significant rise in the number of live births. According to the latest statistics brought forward by the American College of Obstetricians and Gynecology (ACOG) approximately 3.79 million live birth took place in the United States in 2018. Domicile of key manufacturers such as Medline Industries, Inc., Angiplast, Ardo, Medgyn Products Inc., further propel the market growth in the region. Europe is in the 2ndposition in the geography segment for the umbilical cord clamps market. A significant rise in the delayed cord clamping after live births to ensure optimum blood iron level in the newborn primarily determines the market growth in the region. It is expected that the Asia Pacific is keen to register comfortable market growth in the near future on account of huge funding issued by government healthcare agencies for securing women and child health and welfare.

Medical device manufacturers actively manufacturing umbilical cord clamps are Angiplast, Ardo, Medline Industries, Inc., Medgyn Products, Inc., Mediscope International Limited, Surtex Instruments Limited, Denticon Surgical Instruments, Besmed Health Business Corp., Birth Supplies Canada, and R.I.MOS. Srl.

Market Key Takeaways:

  • Increasing number of live births worldwide and rising trend of nurturing new family among adults
  • Significant rise in the demand for polymer-based umbilical cord clamps which are disposable and reduces risk of cross-contamination
  • Effective implementation of guidelines pertaining to obstetrics and gynecology worldwide increasing demand for umbilical cord clamps market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Household Handheld Intraoral Endoscopes Market Is Expected to Grow at a CAGR of 9.4% from 2020 to 2027

According to the latest research citings provided by the World Health Organization (WHO), approximately 3.5 billion people worldwide are suffering from oral diseases. Intraoral endoscopes were developed in the early 1990s in order to replace the mirrors used by dental and maxillofacial surgeons to achieve an excellent view of the oral cavity and its complications and save the images in the patient’s health record for future reference.

Universal serial bus (USB) is spearheading the product type segment for household handheld intraoral endoscopes market. The primary purpose of USB is to provide connection sot electronic gadgets without the need for docking stations and unnecessary use of cables which adds to the exorbitant maintenance cost in the long run. It provides multitasking features from time to time such as ensuring optimum power supply, integration with imaging software to gain a high-resolution image of the oral cavity, etc. Wi-Fi is anticipated to register nimble market growth during the forecast period on account of the technological advancement in Wi-Fi which provides seamless integration with different versions of imaging software. Furthermore, ergonomic features offered by Wi-Fi such as less interference, a faster and excellent range of connectivity with android, and other ios applications will propel its market growth.

Browse the full report Household Handheld Intraoral Endoscopes Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/household-handheld-intraoral-endoscope-market

The supermarket is presently leading the distribution channel segment for household handheld intraoral endoscopes market. The majority of the consumers opt for a one-stop shopping experience on weekends and hence the supermarket serves as a lucrative platform to exhibit intraoral endoscopes of vast diversity at affordable prices. E-commerce is expected to record comfortable market growth in the near future on account of technological advancement in smartphones and increasing internet penetration to bolster its market growth. E-commerce offers discount coupons on festive seasons which attracts huge consumer base across the globe.

North America is currently dominating the geography segment for household handheld intraoral endoscopes market. A significant increase in gingivitis primarily drives market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), in the U.S. approximately 16.9% and 31.6% dental caries are untreated in the children and adult population respectively. Furthermore, the domicile of major players such as Carestream Health, SOTA Imaging, Lensiora, ProDent, etc. further bolsters the market growth in the region. Europe is considered as the second-largest regional segment owing to the strategic collaboration between research academia and medical device manufacturers engaged in the technological development of the household handheld intraoral endoscopes in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period on account of increasing dental complications in people habituated to chewing of betel nuts and tobacco products. The competitive market created by the western giants to the local players will further drive the market growth in the region.

Medical device manufacturers actively engaged in the production of household handheld intraoral endoscopes are Apexel, ProDent, Lensiora, DARYOU Dental, KaVo Dental, SOTA Imaging, Carestream Health, DÜRR DENTAL SE, Dongguan Magenta Technology Co., Ltd., and Shenzhen MingNanHuitai Tech.

Market Key Takeaways:

  • Rising prevalence of oral diseases and dental cavities worldwide
  • Technological advancement in the household handheld intraoral endoscopes will accentuate the market growth
  • The supportive regulatory environment provided by the global healthcare agencies to the distribution of household handheld intraoral endoscopes market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]